Announcements Trials
Browse Landscape

Phase

Phase 2 67Phase 3 13Phase 1/2 11Phase NA 6Phase 1 5Phase 2/3 2

Status

Completed 12Unknown 8Recruiting 5Terminated 3Active not recruiting 2

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 2Tumor-Agnostic 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Stomach Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Meningeal Carcinomatosis 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced Non-Small Cell Lung Cancer 1

Interventions

Cyclophosphamide 118pembrolizumab 104Specimen Handling 104Magnetic Resonance Spectroscopy 94fludarabine 92Biopsy 77Injections 53Nivolumab 43Bevacizumab 41Fluorouracil 38venetoclax 37Cisplatin 36Paclitaxel 35Carboplatin 35Cetuximab 34Radiotherapy 31Oxaliplatin 30fludarabine phosphate 29Leucovorin 28Gemcitabine 28Drug Therapy 25Ipilimumab 23Immunotherapy, Adoptive 23Azacitidine 23Radiation 21Irinotecan 21Temozolomide 20Doxorubicin 20tislelizumab 19atezolizumab 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Recruiting × sintilimab × Clear all
NCT06431685 2026-05-08

Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer

Sichuan University

Phase 1 Recruiting
10 enrolled
CNS

Meningeal Carcinomatosis

NCT07455617 2026-04-06

Study of ABO2102 in KRAS-Mutated Solid Tumors

Suzhou Abogen Biosciences Co., Ltd.

Phase 1 Recruiting
101 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05427487 2026-03-25

Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours

ImmVirx Pty Ltd

Phase 1 Recruiting
70 enrolled
GastrointestinalGynecologic

Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05504278 2025-01-27

Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1 Recruiting
144 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT05979818 2024-11-19

BRIO

Second Xiangya Hospital of Central South University

Phase 1 Recruiting
6 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡